Thursday, August 04, 2016 1:42:18 AM
Including to reference:
http://www.forbes.com/sites/kenkam/2015/03/06/northwest-biotherapeutics-is-a-best-idea/#229010157b3e.
http://www.forbes.com/sites/kenkam/2016/03/23/northwest-bio-is-down-but-not-out/#73e167ce596e
Those views of mine were honed thru two intense decades of professional stock analysis and portfolio manager experience being on the front lines of the investment process beginning with institutional presentations on investing in Japan in the early 1970's to dealing with uncovering hidden value in misunderstood $multi bln multi national industrials to uncovering emerging technology growth co's in the 80's; as well as memorable experiences dealing with successful hedge fund managers on both the long and short side, to even being responsible for a successful proxy contest in unseating a CEO founder of a technology co.
I continue my dedication as a private investor due to being a creature of the markets.I know of no other business that is so challenging and keep one enraptured... if one can keep pace with dynamic change.
Clearly we are dealing with a highly unusual investment vehicle from many perspectives. I was fortunate in exiting NWBO shares the Summer of 2015 due to a strict investment discipline in dramatically reducing equity exposure from a portfolio manager's perspective overruling my love of a stock analyst's perspective due to the confluence of these factors: the longest and most profitable biotech run; the dramatically slowing of the world's most important consumer, the Chinese consumer, in a world of anemic to non existent growth courtesy of the draconian dislocations still plaguing the world caused by the US subprime mortgage exported financial crisis. And I was fortunate in the opportunity to accumulate a large NWBO position below 70 cents. No one can time stock market bottoms consistently. I've only done that a few times.
I, like most, are hopeful NWBO has made lots of progress during this period to share and update it's shareholders soon. With a clearly fortified team found by this Sherlock along with some of these key issues, a lot has happened behind the scenes which one might find interesting: (Tried to be selective here:)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124101297
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123741359
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124099318
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123699010
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123691917
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123564913
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123747658
Branko, we welcome your participation and feedback.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM